Performance of eight‐color dry antibody reagent in the detection of minimal residual disease in chronic lymphocytic leukemia samples-Reference-Cited by-同舟云学术

Performance of eight‐color dry antibody reagent in the detection of minimal residual disease in chronic lymphocytic leukemia samples

Published:2020-04-06 Issue:6 Volume:98 Page:529-535
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Bento Laiz¹,Correia Rodolfo¹,Sousa Flávia¹,Vaz Andressa¹,Pedro Eduardo¹,Schimidell Daniela¹,Millan Nadila¹,Passaro Marilia¹,Barroso Rodrigo¹,Bacal Nydia¹

Affiliation:

1. Flow Cytometry Clinical Laboratory Hospital Isarelita Albert Einstein São Paulo Brazil

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.21875

Reference20 articles.

1. Detection of Minimal Residual Disease in B Cell Acute Lymphoblastic Leukemia Using an Eight‐Color Tube with Dried Antibody Reagents

2. A ten-color tube with dried antibody reagents for the screening of hematological malignancies

3. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

4. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

5. Novel lymphocyte screening tube using dried monoclonal antibody reagents

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Basophil activation in insect venom allergy: comparison of an established test using liquid reagents with a test using 5-color tubes with dried antibody reagents;BMC Immunology;2024-04-27

2. Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia;Cytometry Part B: Clinical Cytometry;2024-03-27

3. Current Landscape of Ancillary Diagnostic Testing in Chronic Lymphocytic Leukemia;Surgical Pathology Clinics;2023-06

4. Measurable residual disease in chronic lymphocytic leukemia;Frontiers in Oncology;2023-02-14

5. Commercial DURAClone panels for extending the repertoire of multicolour immunophenotypic panels in an academic flow cytometry laboratory in South Africa;African Journal of Laboratory Medicine;2022-11-29